Exhibit 4.1


 


AMENDMENT NO. 1 TO REGISTRATION RIGHTS
AGREEMENT


 


This AMENDMENT NO.
1 to THE REGISTRATION RIGHTS AGREEMENT (this “Amendment”), effective as of June 10, 2016, is by and between
BioScrip, Inc. (the “Company”), Coliseum Capital Partners, L.P., a Delaware limited partnership, Coliseum Capital Partners
II, L.P., a Delaware limited partnership and Blackwell Partners, LLC Series A, a Georgia limited liability company (each a “Stockholder”
and collectively, the “Stockholders”).  Capitalized but otherwise undefined
terms herein have the meanings given to them in the Registration Rights Agreement (as defined below).


 


WHEREAS,
the Company and the Stockholders are party to that certain Registration Rights Agreement, dated March 9, 2015 (the “Registration
Rights Agreement”), governing the Company’s obligations to register Registrable Securities of the Stockholders; and


 


WHEREAS, in
connection with entering into that certain Exchange Agreement, dated as of the date hereof, by and between the Company and the
Stockholders pursuant to which the Company will issue shares of Series B Convertible Preferred Stock of the Company in exchange
for shares of Series A Convertible Preferred Stock of the Company, the Company and the Stockholders desire to amend the Registration
Rights Agreement pursuant to Section 11(c) thereof and upon such terms as set forth herein.


 


NOW, THEREFORE, for
good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:


 


1. Amendments
to Registration Rights Agreement.


 


	 	a.	A new definition shall be added to Section 10 of the Registration Rights Agreement to read:


 


““Preferred Stock”
means any shares of Series A Convertible Preferred Stock of the Company, $0.0001 par value per share, or any shares of Series B
Convertible Preferred Stock, $0.0001 par value per share.”


 


	 	b.	The definition of Registrable Securities in Section 10 of the Registration Rights Agreement is hereby amended and restated in its entirety to read as follows:


 


““Registrable Securities”
means the Common Stock that has been or will be issued upon conversion of any Preferred Stock or the exercise of the Warrant, together
with any securities issued or issuable upon any stock split, dividend or other distribution, recapitalization or similar event
with respect to the foregoing. For purposes of this Agreement, a Person shall be deemed to be a holder of Registrable Securities
whenever such Person has the right to acquire such Registrable Securities (upon conversion or exercise, in connection with a transfer
of securities or otherwise, but disregarding any restrictions or limitations upon the exercise of such right), whether or not such
acquisition has actually been effected. As to any particular Registrable Securities, such securities shall cease to be Registrable
Securities when (A) a Registration Statement covering such securities has been declared effective by the Securities and Exchange
Commission and such securities have been disposed of pursuant to such effective Registration Statement, (B) such securities are
sold under circumstances in which all of the applicable conditions of Rule 144 (or any similar provisions then in force) under
the Securities Act are met, (C) such securities are eligible for sale by the Holder without registration pursuant to Rule 144 (or
any similar provisions then in force) under the Securities Act without limitation thereunder on volume or manner of sale, (D) such
securities are otherwise transferred and such securities may be resold without limitation or subsequent registration under the
Securities Act, (E) such securities shall have ceased to be outstanding, or (F) the stock certificates or evidences of book-entry
registration relating to such securities have had all restrictive legends removed.”


 






    	 	 	 



     


    

 


2. Confirmation. Except
as expressly modified by the terms and provisions of this Amendment, all of the terms and provisions of the Registration Rights
Agreement are unchanged and continue in full force and effect and all rights, remedies, liabilities and obligations evidenced by
the Registration Rights Agreement are hereby acknowledged by the Company and the Stockholders to be valid and in full force and
effect.


 


3. Counterparts. This
Amendment may be executed in any number of counterparts, by facsimile if necessary, each of which shall be an original, but all
of which together shall constitute one instrument.


 


4. Governing Law. This
Amendment shall be governed by and construed in accordance with the internal laws of New York applicable to parties residing in
New York, without regard applicable principles of conflicts of law. Each party irrevocably consents to the exclusive jurisdiction
of any court located within New York County, New York, in connection with any matter based upon or arising out of this Amendment
or the matters contemplated hereby and it agrees that process may be served upon it in any manner authorized by the laws of the
State of New York for such persons and waives and covenants not to assert or plead any objection which it might otherwise have
to such jurisdiction and such process.


 


[SIGNATURE PAGES FOLLOW]


 




    	 	- 2 -	 



     


    

 


IN
WITNESS WHEREOF, the parties hereto have caused this Amendment to be executed and delivered as of the date first above
written.


 


	 	COMPANY:
	 	 
	 	BIOSCRIP, INC.
	 	 
	 	 /s/ Richard M. Smith
	 	Name: Richard M. Smith
	 	Title: President & Chief Executive Officer
	 	 
	 	STOCKHOLDERS:
	 	 
	 	COLISEUM CAPITAL PARTNERS, L.P.
	 	COLISEUM CAPITAL PARTNERS II, L.P.
	 	BLACKWELL PARTNERS, LLC SERIES A
	 	 
	 	By: Coliseum Capital Management, LLC as Investment Manager
	 	 
	 	/s/ Adam Gray
	 	Name: Adam Gray
	 	Title: Managing Partner
	 	 
	 	Address: 
	 	One Station Place, 7th Floor South
	 	Stamford, CT 06902


 





[Signature Page to Amendment No. 1 to Registration
Rights Agreement]